Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathis Grossmann

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Australian Family Physician|May 6, 2014
Assessment and management of male androgen disorders: an updateIrene Chan, Mark Ng Tang Fui, Jeffrey D Zajac, et al.
Asia-Pacific Journal of Clinical Oncology|April 10, 2015
Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for managementCrescens Tiu, Carmel Pezaro, Ian D Davis, et al.
Clinical Endocrinology|June 1, 2017
The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatmentMark Ng Tang Fui, Rudolf Hoermann, Jeffrey D Zajac, et al.
Internal Medicine Journal|July 12, 2018
Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcareIngrid Bretherton, Emily Thrower, Mathis Grossmann, et al.
Trials|April 22, 2022
Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Reply to C. Fuchao et alSabashini K Ramchand, Ego Seeman, Rudolf Hoermann, et al.
Journal of Hepatology|June 18, 2016
Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trialMarie Sinclair, Mathis Grossmann, Rudolf Hoermann, et al.
European Journal of Endocrinology|February 22, 2023
Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trialNicholas Russell, Rudolf Hoermann, Ada S Cheung, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 2014
Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trialEmily J Gianatti, Philippe Dupuis, Rudolf Hoermann, et al.
Current Osteoporosis Reports|September 14, 2023
The Utility of Preclinical Models in Understanding the Bone Health of Transgender Individuals Undergoing Gender-Affirming Hormone TherapyVarun S Venkatesh, Tian Nie, Jeffrey D Zajac, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Australian Family Physician|May 6, 2014
Assessment and management of male androgen disorders: an updateIrene Chan, Mark Ng Tang Fui, Jeffrey D Zajac, et al.
Asia-Pacific Journal of Clinical Oncology|April 10, 2015
Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for managementCrescens Tiu, Carmel Pezaro, Ian D Davis, et al.
Clinical Endocrinology|June 1, 2017
The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatmentMark Ng Tang Fui, Rudolf Hoermann, Jeffrey D Zajac, et al.
Internal Medicine Journal|July 12, 2018
Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcareIngrid Bretherton, Emily Thrower, Mathis Grossmann, et al.
Trials|April 22, 2022
Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Reply to C. Fuchao et alSabashini K Ramchand, Ego Seeman, Rudolf Hoermann, et al.
Journal of Hepatology|June 18, 2016
Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trialMarie Sinclair, Mathis Grossmann, Rudolf Hoermann, et al.
European Journal of Endocrinology|February 22, 2023
Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trialNicholas Russell, Rudolf Hoermann, Ada S Cheung, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 2014
Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trialEmily J Gianatti, Philippe Dupuis, Rudolf Hoermann, et al.
Current Osteoporosis Reports|September 14, 2023
The Utility of Preclinical Models in Understanding the Bone Health of Transgender Individuals Undergoing Gender-Affirming Hormone TherapyVarun S Venkatesh, Tian Nie, Jeffrey D Zajac, et al.
Pageof 19